|
Diagnosis: chronic hepatites
Medical institution: Mechnikov State Medical Academy,
Internal Medicine Clinic No. 2
VitaFon treatment course: 13-15 sessions, starting from 10 min. and increasing session time per 1 min. per day (mode 2, application to the right and left lobes of the liver
area). For securing effect repeat treatment every 2-3 months (mode 2, 5 sessions).
|
Blood test parameters
|
Experimental group VitaFon + medicamental therapy
|
Test group medicamental therapy
|
|
Lymphocytes increased
|
From 23% to 33%
|
From 22% to 28%
|
|
Bilirubin concentration reduced
|
By 61%
|
By 40%
|
|
Transaminase activity reduced
|
By 16%
|
By 10%
|
|
Alkaline phosphatase activity reduced
|
By 35%
|
By 22%
|
|
Sublimated titer increased
|
By 12%
|
No proved changes
|
|
Positive dynamics (disappearance of pains; sleep and appetite improvement)
|
90% of patients
|
60% of patients
|
Diagnosis: chronic hepatites B and C
Medical institution:
Military Medical Academy, Infectious Diseases Department
Vibrophones application: liver area with everyday changes of application points
Treatment course: reaferonum - intramuscular per 3 mln. units, 3 times per week; VitaFon - mode 1, per 15 min. once a day, 5 times a week (except Saturday and Sunday).
Results:
|
Groups of patients
|
Remission onset (% of patients)
|
|
without reaferonum
6 months
|
with reaferonum
5 months
|
|
Experimental group
VitaFon +
|
20
|
60
|
|
Test group
VitaFon -
|
0
|
33.3
|
Diagnosis: microcell cirrhosis of the liver
Medical institution:
Mechnikov State Medical Academy, Internal Medicine Clinic No. 2
VitaFon treatment course: 13-15 sessions, starting from 10 min. and increasing
session time per 1 min. per day (mode 2, application to the right and left lobes of the liver area). For securing effect repeat treatment every 2-3 months (mode 2, 5 sessions).
Results:
|
Blood test parameters
|
Experimental group VitaFon medicamental therapy
|
Test group medicamental therapy
|
|
Gammaglobulinum reduced
|
By 16%
|
By 7%
|
|
Transaminase activity reduced
|
By 46%
|
By 31%
|
|
Bilirubin concentration reduced
|
By 66%
|
By 26%
|
Note: The best results were obtained in case of VitaFon combination with
plasmophoresis, low intensity laser radiation and endolymphaic injection of medicine.
|
